These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9788248)
21. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Huuskonen J; Olkkonen VM; Ehnholm C; Metso J; Julkunen I; Jauhiainen M Biochemistry; 2000 Dec; 39(51):16092-8. PubMed ID: 11123937 [TBL] [Abstract][Full Text] [Related]
22. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223 [TBL] [Abstract][Full Text] [Related]
23. Secretion of phospholipid transfer protein by human hepatoma cell line, Hep G2, is enhanced by sodium butyrate. Guo Z; Yuan C; Wei-Lavery T; Fang Y; Garvin RA; Nishida HI; Nishida T J Nutr; 1999 Nov; 129(11):1984-91. PubMed ID: 10539773 [TBL] [Abstract][Full Text] [Related]
24. N-Glycosylation is required for secretion-competent human plasma phospholipid transfer protein. Qu SJ; Fan HZ; Gillard BK; Pownall HJ Protein J; 2006 Feb; 25(2):167-73. PubMed ID: 16862459 [TBL] [Abstract][Full Text] [Related]
26. Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins. Nishida HI; Nishida T J Biol Chem; 1997 Mar; 272(11):6959-64. PubMed ID: 9054384 [TBL] [Abstract][Full Text] [Related]
27. Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells. Desrumaux CM; Mak PA; Boisvert WA; Masson D; Stupack D; Jauhiainen M; Ehnholm C; Curtiss LK J Lipid Res; 2003 Aug; 44(8):1453-61. PubMed ID: 12730304 [TBL] [Abstract][Full Text] [Related]
28. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. Ehnholm S; van Dijk KW; van 't Hof B; van der Zee A; Olkkonen VM; Jauhiainen M; Hofker M; Havekes L; Ehnholm C J Lipid Res; 1998 Jun; 39(6):1248-53. PubMed ID: 9643356 [TBL] [Abstract][Full Text] [Related]
29. Phospholipid transfer protein in lipid metabolism. Huuskonen J; Ehnholm C Curr Opin Lipidol; 2000 Jun; 11(3):285-9. PubMed ID: 10882344 [TBL] [Abstract][Full Text] [Related]
30. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity. Huuskonen J; Ekström M; Tahvanainen E; Vainio A; Metso J; Pussinen P; Ehnholm C; Olkkonen VM; Jauhiainen M Atherosclerosis; 2000 Aug; 151(2):451-61. PubMed ID: 10924722 [TBL] [Abstract][Full Text] [Related]
31. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. Bouly M; Masson D; Gross B; Jiang XC; Fievet C; Castro G; Tall AR; Fruchart JC; Staels B; Lagrost L; Luc G J Biol Chem; 2001 Jul; 276(28):25841-7. PubMed ID: 11342537 [TBL] [Abstract][Full Text] [Related]
32. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. Oka T; Kujiraoka T; Ito M; Egashira T; Takahashi S; Nanjee MN; Miller NE; Metso J; Olkkonen VM; Ehnholm C; Jauhiainen M; Hattori H J Lipid Res; 2000 Oct; 41(10):1651-7. PubMed ID: 11013307 [TBL] [Abstract][Full Text] [Related]
33. Protein C Nagoya, an elongated mutant of protein C, is retained within the endoplasmic reticulum and is associated with GRP78 and GRP94. Katsumi A; Senda T; Yamashita Y; Yamazaki T; Hamaguchi M; Kojima T; Kobayashi S; Saito H Blood; 1996 May; 87(10):4164-75. PubMed ID: 8639775 [TBL] [Abstract][Full Text] [Related]
34. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Huuskonen J; Olkkonen VM; Jauhiainen M; Ehnholm C Atherosclerosis; 2001 Apr; 155(2):269-81. PubMed ID: 11254896 [TBL] [Abstract][Full Text] [Related]
35. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. Tu AY; Nishida HI; Nishida T J Biol Chem; 1993 Nov; 268(31):23098-105. PubMed ID: 8226827 [TBL] [Abstract][Full Text] [Related]
36. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484 [TBL] [Abstract][Full Text] [Related]
37. Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein. Desrumaux C; Athias A; Masson D; Gambert P; Lallemant C; Lagrost L J Lipid Res; 1998 Jan; 39(1):131-42. PubMed ID: 9469592 [TBL] [Abstract][Full Text] [Related]
38. The role of plasma phospholipid transfer protein (PLTP) in HDL remodeling in acute-phase patients. Pussinen PJ; Metso J; Malle E; Barlage S; Palosuo T; Sattler W; Schmitz G; Jauhiainen M Biochim Biophys Acta; 2001 Sep; 1533(2):153-63. PubMed ID: 11566452 [TBL] [Abstract][Full Text] [Related]
39. Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP). Kärkkäinen M; Oka T; Olkkonen VM; Metso J; Hattori H; Jauhiainen M; Ehnholm C J Biol Chem; 2002 May; 277(18):15413-8. PubMed ID: 11854286 [TBL] [Abstract][Full Text] [Related]
40. Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein. Post SM; de Crom R; van Haperen R; van Tol A; Princen HM Arterioscler Thromb Vasc Biol; 2003 May; 23(5):892-7. PubMed ID: 12649089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]